117 related articles for article (PubMed ID: 17526009)
1. Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus.
Yee LJ; Tang YM; Kleiner DE; Wang D; Im K; Wahed A; Tong X; Rhodes S; Su X; Whelan RM; Fontana RJ; Ghany MG; Borg B; Liang TJ; Yang H;
Hepatology; 2007 Jul; 46(1):74-83. PubMed ID: 17526009
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
3. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.
Kimball P; Elswick RK; Shiffman M
J Med Virol; 2001 Nov; 65(3):510-6. PubMed ID: 11596086
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
Barrett S; Collins M; Kenny C; Ryan E; Keane CO; Crowe J
J Med Virol; 2003 Oct; 71(2):212-8. PubMed ID: 12938195
[TBL] [Abstract][Full Text] [Related]
5. Role of cytokine gene (interferon-γ, transforming growth factor-β1, tumor necrosis factor-α, interleukin-6, and interleukin-10) polymorphisms in the risk of oral precancerous lesions in Taiwanese.
Hsu HJ; Yang YH; Shieh TY; Chen CH; Kao YH; Yang CF; Ko EC
Kaohsiung J Med Sci; 2014 Nov; 30(11):551-8. PubMed ID: 25458044
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV.
Delaney NL; Esquenazi V; Lucas DP; Zachary AA; Leffell MS
Hum Immunol; 2004 Dec; 65(12):1413-9. PubMed ID: 15603866
[TBL] [Abstract][Full Text] [Related]
7. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy.
Luo S; Cassidy W; Jeffers L; Reddy KR; Bruno C; Howell CD
Clin Gastroenterol Hepatol; 2005 May; 3(5):499-506. PubMed ID: 15880320
[TBL] [Abstract][Full Text] [Related]
8. Myxovirus resistance 1 gene polymorphisms and outcomes of viral hepatitis B and C infections in Moroccan patients.
Rebbani K; Ababou M; Nadifi S; Kandil M; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
J Med Virol; 2017 Apr; 89(4):647-652. PubMed ID: 27458866
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.
Vidigal PG; Germer JJ; Zein NN
J Hepatol; 2002 Feb; 36(2):271-7. PubMed ID: 11830340
[TBL] [Abstract][Full Text] [Related]
10. Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.
Zhang L; Hao CQ; Miao L; Dou XG
Genet Mol Res; 2014 Nov; 13(4):9747-55. PubMed ID: 25501184
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.
Abbas Z; Moatter T; Hussainy A; Jafri W
World J Gastroenterol; 2005 Nov; 11(42):6656-61. PubMed ID: 16425360
[TBL] [Abstract][Full Text] [Related]
12. Host genetic factors influence disease progression in chronic hepatitis C.
Powell EE; Edwards-Smith CJ; Hay JL; Clouston AD; Crawford DH; Shorthouse C; Purdie DM; Jonsson JR
Hepatology; 2000 Apr; 31(4):828-33. PubMed ID: 10733535
[TBL] [Abstract][Full Text] [Related]
13. The TGFB1 -509C/T polymorphism and elevated TGF-β1 levels are associated with chronic hepatitis C and cirrhosis.
de Brito WB; Queiroz MAF; da Silva Graça Amoras E; Lima SS; da Silva Conde SRS; Dos Santos EJM; Cayres-Vallinoto IMV; Ishak R; Vallinoto ACR
Immunobiology; 2020 Sep; 225(5):152002. PubMed ID: 32962821
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.
Terrault NA; Im K; Boylan R; Bacchetti P; Kleiner DE; Fontana RJ; Hoofnagle JH; Belle SH;
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1403-11. PubMed ID: 19081528
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
Kamar N; Rostaing L; Sandres-Saune K; Selves J; Barthe C; Dubois M; Alric L; Durand D; Izopet J
J Med Virol; 2005 Aug; 76(4):482-8. PubMed ID: 15977245
[TBL] [Abstract][Full Text] [Related]
16. Interaction effects among IFN-γ+874, IL-2-330, IL-10-1082, IL-10-592 and IL-4-589 polymorphisms on the clinical progression of subjects infected with hepatitis B virus and/or hepatitis C virus: a retrospective nested case-control study.
Gao QJ; Xie JX; Wang LM; Zhou Q; Zhang SY
BMJ Open; 2017 Aug; 7(8):e013279. PubMed ID: 28838891
[TBL] [Abstract][Full Text] [Related]
17. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
[TBL] [Abstract][Full Text] [Related]
18. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
[TBL] [Abstract][Full Text] [Related]
19. IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.
Ochi H; Maekawa T; Abe H; Hayashida Y; Nakano R; Imamura M; Hiraga N; Kawakami Y; Aimitsu S; Kao JH; Kubo M; Tsunoda T; Kumada H; Nakamura Y; Hayes CN; Chayama K
J Gen Virol; 2011 May; 92(Pt 5):1071-1081. PubMed ID: 21228123
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
